Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement
about
The housekeeping gene hypoxanthine guanine phosphoribosyltransferase (HPRT) regulates multiple developmental and metabolic pathways of murine embryonic stem cell neuronal differentiationMultiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disordersNatural Phytochemicals in the Treatment and Prevention of Dementia: An OverviewIs the cardiovascular system a therapeutic target for cannabidiol?Neuroinflammation in Alzheimer's diseaseNeuronal seipin knockout facilitates Aβ-induced neuroinflammation and neurotoxicity via reduction of PPARγ in hippocampus of mouseCorrelation Between Cannabidiol-Induced Reduction of Infarct Volume and Inflammatory Factors Expression in Ischemic Stroke Model.Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats.A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.Hippocampal harms, protection and recovery following regular cannabis usePlastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cellsPromising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionWIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.Molecular Targets of Cannabidiol in Neurological DisordersCannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice.VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease.Cell proliferation and neuroblast differentiation in the dentate gyrus of high-fat diet-fed mice are increased after rosiglitazone treatment.Molecular Targets of the Phytocannabinoids: A Complex Picture.The therapeutic potential of the endocannabinoid system for Alzheimer's disease.Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?Cannabidiol in inflammatory bowel diseases: a brief overview.The influence of cannabinoids on generic traits of neurodegeneration.Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.Role of PPAR γ in the Differentiation and Function of NeuronsInvolvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive CannabinoidXanthoceraside modulates neurogenesis to ameliorate cognitive impairment in APP/PS1 transgenic mice.Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.An update on PPAR activation by cannabinoids.Evidences for the Anti-panic Actions of Cannabidiol.Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro.Cannabinoids decrease the th17 inflammatory autoimmune phenotype.The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol.Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link?Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease.
P2860
Q21132509-A3CCBD4D-FC86-4F91-982C-0B7AD8CDC80DQ24623179-F2EAFC9D-07E5-4090-9266-11BB5119B07EQ26750581-540B2A95-19E0-4AB0-A50C-071ABE0A36EBQ26865370-49048914-23D1-4A1E-9ECF-4682877F94FFQ27004226-F25C9DC4-61EE-416A-B977-4D258129D549Q27303098-7BFCB01C-F92F-4185-A947-C634C437BDC9Q33716712-1E24FD5E-1492-4AB6-AD18-032D61E095EAQ33819645-55161C96-3FD5-4489-B59A-52C79ED1344AQ34299290-EC2C0FED-2AAD-4BA6-94ED-EE24E8AD97A7Q34508645-00D89B65-8CC4-4655-B6B8-32BB575DBFBAQ34557613-A47A5936-3FA4-42DF-AE3B-B976D837D7A6Q34700334-37673879-B93E-4BDA-A44B-9092FC1C105DQ35499568-701FD9B8-D731-415B-B0EE-BE1F65CDA2A1Q35601542-DE50B3D6-1AE5-4570-829A-F2D48610260CQ35613040-48818935-D1D0-456C-8FEF-5E7623844F96Q35865445-21FAD33A-8106-4B57-B016-A2424CEB3438Q36157649-384D4E5C-48BA-43DF-AE5A-3C2B56CA3A30Q36785192-F40C840A-6BB9-4EC3-ABBC-0B79D257E1B0Q37105051-4DD027E5-118B-40EE-A556-9669A98B7C37Q37622090-361838B0-4263-45A0-A7B7-A8BCE6A5F8DCQ37681097-AA3614A4-EF9E-43D4-BB9E-ECC209738C79Q37692746-1152B305-E460-49C2-AD41-276B6A63E35AQ37997020-17D8705B-7FE4-4A31-8D76-E3B625A23B66Q38012845-89BFF359-F418-41F7-BEFC-1C5F992FDD12Q38027809-C27F9C9D-33DA-4429-90DB-8401B1139165Q38156518-A08A944D-A11B-45E3-8AA1-11A4990B9604Q38196398-434359CF-F556-43E2-906A-6C2F14AEE16CQ38253356-44CF7416-3437-49BA-BBB7-6984BCA7E770Q38569669-4325A8F8-0EB4-4794-9B7F-62F0C60F1D6AQ38634379-F9D463BE-690C-45AA-903F-A245C9675B1AQ38661043-D939AAE2-B9A5-43E9-9D7E-E13AACCEAA79Q38732473-D04D0926-EEC8-4A2C-B510-8CECAB8BABBAQ38808034-87AC105A-66B8-4731-9DA8-240F29DD0990Q38828985-CD2AF81C-755D-4549-A405-75AB1212AF7AQ39096624-B58DBBF9-BA11-4255-BFAE-900826077E6BQ39119286-0E0EC08D-8CC7-4DFF-9753-E2925AE2B9B2Q39214399-90A1C893-95D4-4DE5-88E7-6938589BA4CCQ39431492-5844DAED-912A-400D-9611-8550DA1A7C22Q40548377-D806241C-8FB8-497C-B755-E9EDD2A38E2CQ42580206-8DC7A7EE-1D9D-4B10-88B0-A8B9F71430F8
P2860
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cannabidiol reduces Aβ-induced ...... esis through PPARγ involvement
@ast
Cannabidiol reduces Aβ-induced ...... esis through PPARγ involvement
@en
Cannabidiol reduces Aβ-induced ...... esis through PPARγ involvement
@nl
type
label
Cannabidiol reduces Aβ-induced ...... esis through PPARγ involvement
@ast
Cannabidiol reduces Aβ-induced ...... esis through PPARγ involvement
@en
Cannabidiol reduces Aβ-induced ...... esis through PPARγ involvement
@nl
prefLabel
Cannabidiol reduces Aβ-induced ...... esis through PPARγ involvement
@ast
Cannabidiol reduces Aβ-induced ...... esis through PPARγ involvement
@en
Cannabidiol reduces Aβ-induced ...... esis through PPARγ involvement
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Cannabidiol reduces Aβ-induced ...... esis through PPARγ involvement
@en
P2093
Daniele De Filippis
Giuseppina Ines Togna
Teresa Iuvone
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0028668
P407
P50
P577
2011-12-05T00:00:00Z